<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-4c18-79df-014c-2d6122a30a44</uuid><title>Venous Thromboembolism Patients Receiving Unfractionated Heparin with Dosages/Platelet Count Monitoring by Protocol or Nomogram</title><shortTitle>Venous Thromboembolism Patients</shortTitle><emeasureid>109</emeasureid><guid>bcce43dd-08e3-46c3-bfdd-0b1b472690f0</guid><version>4.0.000</version><nqfid extension="Not Applicable" root="2.16.840.1.113883.3.560.1"/><period calenderYear="true" uuid="40280381-3cd1-4954-013d-12b735d01c2f"><startDate>00000101</startDate><stopDate>00001231</stopDate></period><steward id="1.3.6.1.4.1.33895">The Joint Commission</steward><developers><developer id="1.3.6.1.4.1.33895">The Joint Commission</developer></developers><description>This measure assesses the number of patients diagnosed with confirmed VTE who received intravenous (IV) UFH therapy dosages AND had their platelet counts monitored using defined parameters such as a nomogram or protocol.</description><copyright>Measure specifications are in the Public Domain.&#xD;
&#xD;
LOINC(R) is a registered trademark of the Regenstrief Institute.&#xD;
&#xD;
This material contains SNOMED Clinical Terms(R) (SNOMED CT(C)) copyright 2004-2014 International Health Terminology Standards Development Organization. All rights reserved.</copyright><disclaimer>These performance measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The measures and specifications are provided without warranty.</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><componentMeasures/><itemCount><elementRef dataType="Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" name="Encounter Inpatient" oid="2.16.840.1.113883.3.666.5.307"/></itemCount><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>Heparin is commonly involved in adverse drug events (Geerts et al., 2008). Sub-therapeutic and supratherapeutic levels can lead to thromboembolic or bleeding complications that may increase the patient's length of stay. The use of weight-based nomograms has increased the likelihood that a therapeutic partial prothromboplastin time (aPTT) will be achieved within the first 24 to 48 hours of therapy. The risk of recurrent thromboembolism is reduced when a therapeutic level of heparin is reached quickly. Unfractionated heparin (UFH) management by weight-based aPTT adjusted protocols have demonstrated their ability through clinical trials to achieve a therapeutic aPTT more rapidly than with standard UFH dosing without increasing major bleeding (Rashke et al., 1993).&#xD;
&#xD;
Heparin nomograms are superior compared to routine care in the timely achievement of therapeutic anticoagulation despite the trend toward patients having aPTTs above the target range (http://archive.ahrq.gov/clinic/ptsafety/chap9.htm, retrieved March 13, 2015). Heparin-induced thrombocytopenia (HIT) occurs more commonly in patients who receive UFH than in those who receive low molecular weight heparin (Martel et al., 2005). HIT is defined as an unexplained fall in platelet count (specifically, a 50% fall in platelet count from baseline, even if the platelet count remains above 150 x 109/L) (Warkentin et al., 2003). Platelet counts generally begin to fall 5-10 days after the initiation of heparin therapy. Prompt recognition of HIT is important so that heparin can be discontinued and the risk of venous and arterial thrombosis minimized. To detect HIT, platelet count monitoring is recommended for all patients treated with UFH (Warkentin et al., 2003).</rationale><recommendations>Heparin-induced thrombocytopenia (HIT) may occur in patients who receive unfractionated heparin (UHF) for treatment of thromboembolism. Prompt recognition of HIT by evaluation of platelet counts can allow for detection of HIT, and the subsequent discontinuation of UFH.  Management of UFH by nomogram/protocol is recommended to decrease the time outside of the therapeutic range.</recommendations><improvementNotations>Improvement noted as an increase in rate</improvementNotations><references><reference>Gandi TK, Shojania KG, Bates DW. Chapter 9. Protocols for High-Risk Drugs: Reducing Adverse Drugs Events Related to Anticoagulants. Retrieved from the World Wide Web at http://archive.ahrq.gov/clinic/ptsafety/chap9.htm accessed on March 13, 2015.</reference><reference>Geerts WH, Bergquist D., Pineo,GF., Heit, J.A., Samama, CM., Lassen, MR., Colwell, CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). CHEST. 2008:133; 381-453.</reference><reference>Guyatt, G.H., Akl, E.A., Crowther, M., Gutterman, D., Schunemann, H. Antithromboitic Therapy and Prevention of Thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST 2012; 141(2) (Supp):7S-47S.</reference><reference>Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e419S-94S.</reference><reference>Martel, N., Lee, J., and Wells, P.S. Risk for heparin induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 2005 June; 106:2710-2715.</reference><reference>Raschke RA, Reilly BM, Guidry JR et al. The weight-based heparin dosing nomogram compared with 'standard care' nomogram. Ann Intern Med. 1993 Nov 1; 119(9):874-81.</reference><reference>Warkentin TE, Roberts RS, Hirsh J, et al. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 2003; 163:2518-24.</reference></references><definitions>None</definitions><guidance>CMS recognizes the difficulty in capturing the VTE confirmed concept required in this measure and suggests eligible hospitals participating in the Medicare &amp; Medicaid EHR Incentive Programs consider selecting alternative electronic clinical quality measures (eCQMs) to meet program requirements for meaningful use. If suitable alternatives are unavailable, CMS will accept a 0 denominator submission for the eCQM version only for this measure. &#xD;
&#xD;
The unit of measurement for this measure is an inpatient episode of care. Each distinct hospitalization should be reported, regardless of whether the same patient is admitted for inpatient care more than once during the measurement period. In addition, the eMeasure logic intends to represent events within or surrounding a single occurrence of an inpatient hospitalization.&#xD;
&#xD;
Treatment adjustment by protocol and/or use of a clinical pathway must be specific to unfractionated heparin therapy. Heparin protocols and clinical pathways may include use of a nomogram.&#xD;
&#xD;
The construct of Unfractionated Heparin (route: 'Intravenous route') intends to capture continually infused heparin rather than heparin flushes or pushes.</guidance><transmissionFormat>TBD</transmissionFormat><initialPopDescription>Patients age 18 and older discharged from hospital inpatient acute care during the measurement period with a length of stay less than or equal to 120 days and a diagnosis of venous thromboembolism (VTE) </initialPopDescription><denominatorDescription>Patients with VTE confirmed through a diagnostic test and receiving IV UFH therapy</denominatorDescription><denominatorExclusionsDescription>Patients with comfort measures documented&#xD;
Patients discharged to an acute care facility &#xD;
Patients who left against medical advice&#xD;
Patients who expired&#xD;
Patients discharged to home for hospice care&#xD;
Patients discharged to a health care facility for hospice care</denominatorExclusionsDescription><numeratorDescription>Patients who have their IV UFH therapy dosages and platelet counts monitored according to defined parameters such as a nomogram or protocol.</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>None</denominatorExceptionsDescription><measurePopulationDescription>Not Applicable</measurePopulationDescription><measurePopulationExclusionsDescription>Not Applicable</measurePopulationExclusionsDescription><measureObservationsDescription>Not Applicable</measureObservationsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</supplementalData><qualityMeasureSet uuid="ae2824b5-b2fa-461a-88fb-6f91b7030b3c">eMeasure Venous Thromboembolism (eVTE)</qualityMeasureSet>
<finalizedDate value="201503301121-0500"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3cd1-4954-013d-12b735d01c29" name="Ethnicity"/><elementRef id="40280381-3cd1-4954-013d-12b735cf1c27" name="ONC Administrative Sex"/><elementRef id="40280381-3cd1-4954-013d-12b735d01c2a" name="Payer"/><elementRef id="40280381-3cd1-4954-013d-12b735cf1c28" name="Race"/></supplementalDataElements><riskAdjustmentVariables/><subTreeLookUp><subTree displayName="EncounterInpatient" qdmVariable="true" uuid="136FAC67-C762-4380-B367-34FC6D4C754F"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"><attribute attrUUID="48c43618-1012-45b1-a809-9c5b664790f9" comparisonValue="120" mode="Less Than Or Equal To" name="length of stay" unit="days"/></elementRef><relationalOp displayName="Ends During" type="EDU"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3cd1-4954-013d-12b735d01c2f" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="DiagnosisVTE" qdmVariable="true" uuid="193FFD7F-2E0E-4FCA-9B59-5B99C1F70B83"><setOp displayName="UNION" type="union"><elementRef displayName="Venous Thromboembolism : Diagnosis, Active" id="40280381-3cd1-4954-013d-12b735d21c4c" type="qdm"/><elementRef displayName="Obstetrics VTE : Diagnosis, Active" id="40280381-3cd1-4954-013d-12b735d01c2c" type="qdm"/></setOp></subTree><subTree displayName="Occurrence A of $EncounterInpatient" instance="A" instanceOf="136FAC67-C762-4380-B367-34FC6D4C754F" qdmVariable="true" uuid="452C7083-15BF-4004-B01B-4781CD0B4B9D"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"><attribute attrUUID="48c43618-1012-45b1-a809-9c5b664790f9" comparisonValue="120" mode="Less Than Or Equal To" name="length of stay" unit="days"/></elementRef><relationalOp displayName="Ends During" type="EDU"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3cd1-4954-013d-12b735d01c2f" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="InterventionComfortMeasures" qdmVariable="true" uuid="C40D3A53-15C5-418C-A2D8-0A68E10488F7"><setOp displayName="UNION" type="union"><elementRef displayName="Comfort Measures  : Intervention, Order" id="f868f926-3174-47bd-b8bd-49a879e012b4" type="qdm"/><elementRef displayName="Comfort Measures  : Intervention, Performed" id="beb49e3a-8d18-4c43-abd7-f98a8d88bb10" type="qdm"/></setOp></subTree><subTree displayName="Age GTET 18 years at Occ A EncIP" qdmVariable="false" uuid="82E9E6B2-1A42-4242-B7DE-37DAB028F8B4"><functionalOp displayName="Age &gt;= 18 years at" operatorType="Greater Than or Equal To" quantity="18" type="AGE AT" unit="years"><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/></functionalOp></subTree><subTree displayName="DiagVTE starts during Occ A EncIP" qdmVariable="false" uuid="F3C75BD7-4D5D-4DB4-B4BB-D0AC63667748"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="DiagnosisVTE" id="193FFD7F-2E0E-4FCA-9B59-5B99C1F70B83" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/></relationalOp></subTree><subTree displayName="InterventionComfortMsrs starts during Occ A EncIP" qdmVariable="false" uuid="8FA501A1-5CC2-49F1-B55D-75F3FD8E06BD"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="InterventionComfortMeasures" id="C40D3A53-15C5-418C-A2D8-0A68E10488F7" type="subTree"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/></relationalOp></subTree><subTree displayName="Intersection of Occ A EncIP Enc Perf Enc IP sat any DC statuses" qdmVariable="false" uuid="3B3BBAC9-DD8D-4048-AB69-A1A86AFA65F6"><setOp displayName="INTERSECTION" type="intersection"><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/><functionalOp displayName="SATISFIES ANY" type="SATISFIES ANY"><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"/><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"><attribute attrUUID="e294fa05-8d78-4903-9c90-03f585531d31" mode="Value Set" name="discharge status" qdmUUID="40280381-3cd1-4954-013d-12b735d11c47"/></elementRef><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"><attribute attrUUID="c1f915e5-ea01-4de2-aa5c-abdb39bcb131" mode="Value Set" name="discharge status" qdmUUID="40280381-3cd1-4954-013d-12b735d11c3e"/></elementRef><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"><attribute attrUUID="73deb240-9992-4024-a1e8-204f94b8f09c" mode="Value Set" name="discharge status" qdmUUID="40280381-3cd1-4954-013d-12b735d11c45"/></elementRef><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"><attribute attrUUID="65bdb753-6711-4c69-b970-2953995b1d9f" mode="Value Set" name="discharge status" qdmUUID="40280381-3cd1-4954-013d-12b735d11c3d"/></elementRef><elementRef displayName="Encounter Inpatient : Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" type="qdm"><attribute attrUUID="f464927d-b259-49d5-923e-c84b680620b6" mode="Value Set" name="discharge status" qdmUUID="40280381-3cd1-4954-013d-12b735d11c3c"/></elementRef></functionalOp></setOp></subTree><subTree displayName="Med Adm Unfract Heparin route Intravenous starts during Occ A EncIP" qdmVariable="false" uuid="3AF3A0EC-EB97-4808-A687-F2A3A5C97708"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Unfractionated Heparin : Medication, Administered" id="40280381-3cd1-4954-013d-12b735d01c32" type="qdm"><attribute attrUUID="ca9b5e8a-2bb5-4575-9ee8-6ba518ee2890" mode="Value Set" name="route" qdmUUID="40280381-3cd1-4954-013d-12b735d11c40"/></elementRef><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/></relationalOp></subTree><subTree displayName="ED Visit LTET 1h EBOCWS Occ A EncIP" qdmVariable="false" uuid="C218FC29-32D7-4832-BBA7-644BC0AE9E91"><relationalOp displayName="&lt;= 1 hours Ends Before Or Concurrent With Start Of" operatorType="Less Than or Equal To" quantity="1" type="EBSORECWS" unit="hours"><elementRef displayName="Emergency Department Visit : Encounter, Performed" id="1c1e01b2-682c-463c-9ffc-b6b039f63d27" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/></relationalOp></subTree><subTree displayName="DiagVTE starts during ED Visit LTET 1h EBOCWS OccA EncIP" qdmVariable="false" uuid="EC972267-F45A-4040-8532-5588F73E38EB"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="DiagnosisVTE" id="193FFD7F-2E0E-4FCA-9B59-5B99C1F70B83" type="subTree"/><subTreeRef displayName="ED Visit LTET 1h EBOCWS Occ A EncIP" id="C218FC29-32D7-4832-BBA7-644BC0AE9E91" type="subTree"/></relationalOp></subTree><subTree displayName="DiagStudyPerf VTE Diag sat all result VTE Conf sat any 4 timings" qdmVariable="false" uuid="A8449B38-055E-4181-8B6A-F3A7E7908251"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="VTE Diagnostic Test : Diagnostic Study, Performed" id="eaf0525b-427a-4da9-894d-d2c7c26ed180" type="qdm"/><elementRef displayName="VTE Diagnostic Test : Diagnostic Study, Performed" id="eaf0525b-427a-4da9-894d-d2c7c26ed180" type="qdm"><attribute attrUUID="3b096227-c0a1-45e0-9c2a-44ad73358af2" mode="Value Set" name="result" qdmUUID="40280381-3cd1-4954-013d-12b735d21c54"/></elementRef><functionalOp displayName="SATISFIES ANY" type="SATISFIES ANY"><elementRef displayName="VTE Diagnostic Test : Diagnostic Study, Performed" id="eaf0525b-427a-4da9-894d-d2c7c26ed180" type="qdm"/><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="VTE Diagnostic Test : Diagnostic Study, Performed" id="eaf0525b-427a-4da9-894d-d2c7c26ed180" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/></relationalOp><relationalOp displayName="&lt;= 4 days Starts Before Start Of" operatorType="Less Than or Equal To" quantity="4" type="SBS" unit="days"><elementRef displayName="VTE Diagnostic Test : Diagnostic Study, Performed" id="eaf0525b-427a-4da9-894d-d2c7c26ed180" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/></relationalOp><relationalOp displayName="&lt;= 4 days Starts Before Start Of" operatorType="Less Than or Equal To" quantity="4" type="SBS" unit="days"><elementRef displayName="VTE Diagnostic Test : Diagnostic Study, Performed" id="eaf0525b-427a-4da9-894d-d2c7c26ed180" type="qdm"/><subTreeRef displayName="ED Visit LTET 1h EBOCWS Occ A EncIP" id="C218FC29-32D7-4832-BBA7-644BC0AE9E91" type="subTree"/></relationalOp><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="VTE Diagnostic Test : Diagnostic Study, Performed" id="eaf0525b-427a-4da9-894d-d2c7c26ed180" type="qdm"/><subTreeRef displayName="ED Visit LTET 1h EBOCWS Occ A EncIP" id="C218FC29-32D7-4832-BBA7-644BC0AE9E91" type="subTree"/></relationalOp></functionalOp></functionalOp></subTree><subTree displayName="Med Adm Unfract Heparin route Intravenous starts during ED Visit LTET 1h EB" qdmVariable="false" uuid="2D28CC3A-6A1E-47B5-B567-2C08ECBFD604"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Unfractionated Heparin : Medication, Administered" id="40280381-3cd1-4954-013d-12b735d01c32" type="qdm"><attribute attrUUID="569e7fcc-b033-4b25-b5b7-2bdde22d7e70" mode="Value Set" name="route" qdmUUID="40280381-3cd1-4954-013d-12b735d11c40"/></elementRef><subTreeRef displayName="ED Visit LTET 1h EBOCWS Occ A EncIP" id="C218FC29-32D7-4832-BBA7-644BC0AE9E91" type="subTree"/></relationalOp></subTree><subTree displayName="InterventionComfortMsrs starts during ED Visit LTET 1h EBOCWS OccA EncIP" qdmVariable="false" uuid="215E2DF6-653C-4775-9361-5D5603FDC608"><relationalOp displayName="Starts During" type="SDU"><subTreeRef displayName="InterventionComfortMeasures" id="C40D3A53-15C5-418C-A2D8-0A68E10488F7" type="subTree"/><subTreeRef displayName="ED Visit LTET 1h EBOCWS Occ A EncIP" id="C218FC29-32D7-4832-BBA7-644BC0AE9E91" type="subTree"/></relationalOp></subTree><subTree displayName="Union of TreatAdjByProt sat all ClinicalPathProt sat all" qdmVariable="false" uuid="94795A93-AA70-4D07-BF9C-0A3C5BF2E941"><setOp displayName="UNION" type="union"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="Treatment Adjusted by Protocol : Procedure, Performed" id="40280381-3cd1-4954-013d-12b735d21c57" type="qdm"/><relationalOp displayName="Starts After Or Concurrent With Start Of" type="SASORSCW"><elementRef displayName="Treatment Adjusted by Protocol : Procedure, Performed" id="40280381-3cd1-4954-013d-12b735d21c57" type="qdm"/><elementRef displayName="Occurrence A of Unfractionated Heparin : Medication, Order" id="40280381-3cd1-4954-013d-12b735d21c56" type="qdm"><attribute attrUUID="a00a0696-dba1-4007-9280-e7200c593fdb" mode="Value Set" name="route" qdmUUID="40280381-3cd1-4954-013d-12b735d11c40"/></elementRef></relationalOp><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Treatment Adjusted by Protocol : Procedure, Performed" id="40280381-3cd1-4954-013d-12b735d21c57" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/></relationalOp></functionalOp><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="Clinical Pathway Protocol : Procedure, Performed" id="40280381-3cd1-4954-013d-12b735d21c58" type="qdm"/><relationalOp displayName="Starts After Or Concurrent With Start Of" type="SASORSCW"><elementRef displayName="Clinical Pathway Protocol : Procedure, Performed" id="40280381-3cd1-4954-013d-12b735d21c58" type="qdm"/><elementRef displayName="Occurrence A of Unfractionated Heparin : Medication, Order" id="40280381-3cd1-4954-013d-12b735d21c56" type="qdm"><attribute attrUUID="7595c3a0-fe7a-46a2-a8ad-532545d81549" mode="Value Set" name="route" qdmUUID="40280381-3cd1-4954-013d-12b735d11c40"/></elementRef></relationalOp><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Clinical Pathway Protocol : Procedure, Performed" id="40280381-3cd1-4954-013d-12b735d21c58" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/></relationalOp></functionalOp></setOp></subTree><subTree displayName="Lab Test Perf Platelet Count sat all SAS Med Order Unfract Hep during Occ A" qdmVariable="false" uuid="E3F6B3A8-378B-4E0A-8C8B-ECFA0F039CD9"><functionalOp displayName="SATISFIES ALL" type="SATISFIES ALL"><elementRef displayName="Platelet Count : Laboratory Test, Performed" id="40280381-3cd1-4954-013d-12b735d21c59" type="qdm"/><relationalOp displayName="Starts After Start Of" type="SAS"><elementRef displayName="Platelet Count : Laboratory Test, Performed" id="40280381-3cd1-4954-013d-12b735d21c59" type="qdm"/><elementRef displayName="Occurrence A of Unfractionated Heparin : Medication, Order" id="40280381-3cd1-4954-013d-12b735d21c56" type="qdm"><attribute attrUUID="1bb18141-c904-49cb-ab4f-87243c88374a" mode="Value Set" name="route" qdmUUID="40280381-3cd1-4954-013d-12b735d11c40"/></elementRef></relationalOp><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Platelet Count : Laboratory Test, Performed" id="40280381-3cd1-4954-013d-12b735d21c59" type="qdm"/><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/></relationalOp></functionalOp></subTree><subTree displayName="Med Order Unfract Heparin starts during Occ A EncIP" qdmVariable="false" uuid="1711F7F7-7393-4388-812A-E4F43FF6CAE3"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of Unfractionated Heparin : Medication, Order" id="40280381-3cd1-4954-013d-12b735d21c56" type="qdm"><attribute attrUUID="e550f9b6-5b74-447f-9353-88c2ecc951d6" mode="Value Set" name="route" qdmUUID="40280381-3cd1-4954-013d-12b735d11c40"/></elementRef><subTreeRef displayName="Occurrence A of EncounterInpatient" id="452C7083-15BF-4004-B01B-4781CD0B4B9D" type="subTree"/></relationalOp></subTree><subTree displayName="Med Order Unfract Heparin starts during ED Visit LTET 1h EBOCWS OccA EncIP" qdmVariable="false" uuid="7A78778A-9957-434D-B079-294E86F8A3EE"><relationalOp displayName="Starts During" type="SDU"><elementRef displayName="Occurrence A of Unfractionated Heparin : Medication, Order" id="40280381-3cd1-4954-013d-12b735d21c56" type="qdm"><attribute attrUUID="97204eff-028b-471d-854f-1217079bd58a" mode="Value Set" name="route" qdmUUID="40280381-3cd1-4954-013d-12b735d11c40"/></elementRef><subTreeRef displayName="ED Visit LTET 1h EBOCWS Occ A EncIP" id="C218FC29-32D7-4832-BBA7-644BC0AE9E91" type="subTree"/></relationalOp></subTree></subTreeLookUp><measureGrouping><group sequence="1"><clause displayName="Initial Population 1" type="initialPopulation" uuid="6DC0E9D1-3492-4F6F-B807-D57E442A9ABC"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age GTET 18 years at Occ A EncIP" id="82E9E6B2-1A42-4242-B7DE-37DAB028F8B4" type="subTree"/><logicalOp displayName="OR" type="or"><subTreeRef displayName="DiagVTE starts during Occ A EncIP" id="F3C75BD7-4D5D-4DB4-B4BB-D0AC63667748" type="subTree"/><subTreeRef displayName="DiagVTE starts during ED Visit LTET 1h EBOCWS OccA EncIP" id="EC972267-F45A-4040-8532-5588F73E38EB" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="E35059CA-91F5-41D5-B759-4D38CB7EF655"><logicalOp displayName="AND" type="and"><subTreeRef displayName="DiagStudyPerf VTE Diag sat all result VTE Conf sat any 4 timings" id="A8449B38-055E-4181-8B6A-F3A7E7908251" type="subTree"/><logicalOp displayName="OR" type="or"><comment displayName="comment" type="comment"/><subTreeRef displayName="Med Adm Unfract Heparin route Intravenous starts during ED Visit LTET 1h EB" id="2D28CC3A-6A1E-47B5-B567-2C08ECBFD604" type="subTree"/><subTreeRef displayName="Med Adm Unfract Heparin route Intravenous starts during Occ A EncIP" id="3AF3A0EC-EB97-4808-A687-F2A3A5C97708" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></logicalOp></clause><clause displayName="Denominator Exclusions 2" type="denominatorExclusions" uuid="49FD5C18-793F-4604-A441-A3405EE08D60"><logicalOp displayName="OR" type="or"><comment displayName="comment" type="comment"/><subTreeRef displayName="InterventionComfortMsrs starts during ED Visit LTET 1h EBOCWS OccA EncIP" id="215E2DF6-653C-4775-9361-5D5603FDC608" type="subTree"/><subTreeRef displayName="InterventionComfortMsrs starts during Occ A EncIP" id="8FA501A1-5CC2-49F1-B55D-75F3FD8E06BD" type="subTree"/><subTreeRef displayName="Intersection of Occ A EncIP Enc Perf Enc IP sat any DC statuses" id="3B3BBAC9-DD8D-4048-AB69-A1A86AFA65F6" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="1B95635F-783E-40C2-88FC-169E5A9B6F1E"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><subTreeRef displayName="Med Order Unfract Heparin starts during Occ A EncIP" id="1711F7F7-7393-4388-812A-E4F43FF6CAE3" type="subTree"/><subTreeRef displayName="Med Order Unfract Heparin starts during ED Visit LTET 1h EBOCWS OccA EncIP" id="7A78778A-9957-434D-B079-294E86F8A3EE" type="subTree"/></logicalOp><subTreeRef displayName="Union of TreatAdjByProt sat all ClinicalPathProt sat all" id="94795A93-AA70-4D07-BF9C-0A3C5BF2E941" type="subTree"/><subTreeRef displayName="Lab Test Perf Platelet Count sat all SAS Med Order Unfract Hep during Occ A" id="E3F6B3A8-378B-4E0A-8C8B-ECFA0F039CD9" type="subTree"><comment displayName="comment" type="comment"/></subTreeRef></logicalOp></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="c3861ebe-b1ff-4e4a-86bc-60bc371ac161"><logicalOp displayName="AND" type="and"/></clause><clause displayName="denominatorExceptions" type="denominatorExceptions" uuid="6036fb7a-9efc-4538-832d-28e106f40560"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="b422a032-9ea9-47a2-b66b-0b7852abecd5"/></group></measureGrouping><elementLookUp><qdm datatype="Patient Characteristic Birthdate" id="ed37b02e-79ac-4287-97fb-c65fc74f5172" name="Birthdate" oid="21112-8" suppDataElement="false" taxonomy="SNOMED-CT" uuid="ed37b02e-79ac-4287-97fb-c65fc74f5172" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Procedure, Performed" id="40280381-3cd1-4954-013d-12b735d21c58" name="Clinical Pathway Protocol" oid="2.16.840.1.113883.3.117.1.7.1.253" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013d-12b735d21c58" version="1"/><qdm datatype="Intervention, Order" id="f868f926-3174-47bd-b8bd-49a879e012b4" name="Comfort Measures " oid="1.3.6.1.4.1.33895.1.3.0.45" suppDataElement="false" taxonomy="SNOMEDCT" uuid="f868f926-3174-47bd-b8bd-49a879e012b4" version="1.0"/><qdm datatype="Intervention, Performed" id="beb49e3a-8d18-4c43-abd7-f98a8d88bb10" name="Comfort Measures " oid="1.3.6.1.4.1.33895.1.3.0.45" suppDataElement="false" taxonomy="SNOMEDCT" uuid="beb49e3a-8d18-4c43-abd7-f98a8d88bb10" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013d-12b735d11c47" name="Discharge To Acute Care Facility" oid="2.16.840.1.113883.3.117.1.7.1.87" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013d-12b735d11c47" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013d-12b735d11c3c" name="Discharged to Health Care Facility for Hospice Care" oid="2.16.840.1.113883.3.117.1.7.1.207" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013d-12b735d11c3c" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013d-12b735d11c3d" name="Discharged to Home for Hospice Care" oid="2.16.840.1.113883.3.117.1.7.1.209" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013d-12b735d11c3d" version="1"/><qdm datatype="Encounter, Performed" id="1c1e01b2-682c-463c-9ffc-b6b039f63d27" name="Emergency Department Visit" oid="2.16.840.1.113883.3.117.1.7.1.292" suppDataElement="false" taxonomy="SNOMEDCT" uuid="1c1e01b2-682c-463c-9ffc-b6b039f63d27" version="1.0"/><qdm datatype="Encounter, Performed" id="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" name="Encounter Inpatient" oid="2.16.840.1.113883.3.666.5.307" suppDataElement="false" taxonomy="SNOMEDCT" uuid="7ab3d866-68fa-4d71-bc70-b6724e5de4cf" version="1.0"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3cd1-4954-013d-12b735d01c29" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3cd1-4954-013d-12b735d01c29" version="1"/><qdm datatype="Patient Characteristic Expired" id="f0b94a66-11be-4d8e-a2a7-3fb06c9e13cd" name="Expired" oid="419099009" suppDataElement="false" taxonomy="SNOMED-CT" uuid="f0b94a66-11be-4d8e-a2a7-3fb06c9e13cd" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013d-12b735d11c40" name="Intravenous route" oid="2.16.840.1.113883.3.117.1.7.1.222" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013d-12b735d11c40" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013d-12b735d11c3e" name="Left Against Medical Advice" oid="2.16.840.1.113883.3.117.1.7.1.308" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013d-12b735d11c3e" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3cd1-4954-013d-12b735d01c2f" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3cd1-4954-013d-12b735d01c2f" version="1"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3cd1-4954-013d-12b735d01c2c" name="Obstetrics VTE" oid="2.16.840.1.113883.3.117.1.7.1.264" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3cd1-4954-013d-12b735d01c2c" version="1"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3cd1-4954-013d-12b735cf1c27" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeGender" uuid="40280381-3cd1-4954-013d-12b735cf1c27" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013d-12b735d11c45" name="Patient Expired" oid="2.16.840.1.113883.3.117.1.7.1.309" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013d-12b735d11c45" version="1"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3cd1-4954-013d-12b735d01c2a" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3cd1-4954-013d-12b735d01c2a" version="1"/><qdm codeSystemName="Joint Commission" datatype="Laboratory Test, Performed" id="40280381-3cd1-4954-013d-12b735d21c59" name="Platelet Count" oid="2.16.840.1.113883.3.117.1.7.1.267" suppDataElement="false" taxonomy="LOINC" uuid="40280381-3cd1-4954-013d-12b735d21c59" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3cd1-4954-013d-12b735cf1c28" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3cd1-4954-013d-12b735cf1c28" version="1"/><qdm codeSystemName="Joint Commission" datatype="Procedure, Performed" id="40280381-3cd1-4954-013d-12b735d21c57" name="Treatment Adjusted by Protocol" oid="2.16.840.1.113883.3.117.1.7.1.278" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013d-12b735d21c57" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Administered" id="40280381-3cd1-4954-013d-12b735d01c32" name="Unfractionated Heparin" oid="2.16.840.1.113883.3.117.1.7.1.218" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3cd1-4954-013d-12b735d01c32" version="1"/><qdm codeSystemName="Joint Commission" datatype="Medication, Order" id="40280381-3cd1-4954-013d-12b735d21c56" instance="Occurrence A" name="Unfractionated Heparin" oid="2.16.840.1.113883.3.117.1.7.1.218" suppDataElement="false" taxonomy="RXNORM" uuid="40280381-3cd1-4954-013d-12b735d21c56" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Diagnosis, Active" id="40280381-3cd1-4954-013d-12b735d21c4c" name="Venous Thromboembolism" oid="2.16.840.1.113883.3.117.1.7.1.279" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3cd1-4954-013d-12b735d21c4c" version="1"/><qdm codeSystemName="Joint Commission" datatype="attribute" id="40280381-3cd1-4954-013d-12b735d21c54" name="VTE Confirmed" oid="2.16.840.1.113883.3.117.1.7.1.407" suppDataElement="false" taxonomy="SNOMEDCT" uuid="40280381-3cd1-4954-013d-12b735d21c54" version="1"/><qdm datatype="Diagnostic Study, Performed" id="eaf0525b-427a-4da9-894d-d2c7c26ed180" name="VTE Diagnostic Test" oid="2.16.840.1.113883.3.117.1.7.1.276" suppDataElement="false" taxonomy="Grouping" uuid="eaf0525b-427a-4da9-894d-d2c7c26ed180" version="1.0"/><qdm codeSystemName="Joint Commission" datatype="Medication, Order" id="9065687d-2f0c-4f52-94b7-5e7f395c704f" name="Unfractionated Heparin" oid="2.16.840.1.113883.3.117.1.7.1.218" suppDataElement="false" taxonomy="RXNORM" uuid="9065687d-2f0c-4f52-94b7-5e7f395c704f" version="1.0"/></elementLookUp></measure>